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Abstract - Aryl semicarbazide derivatives are reported to possess anticonvulsant activity. On the other hand unsubstituted and small
substituents (less than 3 carbon atom) containing cyclohexanones prevented both pentylenetetrazole and MES induced seizures.
Similarly cycloheptanone fused with benzodiazepine and furan produced anticonvulsant compounds. Therefore looking into the
above facts in the present study, we have synthesized 12 derivatives of 1-cyclohexylidine/cycloheptylidine-4-substitued
semicarbazide derivatives and screened them for anticonvulsant activity.
The synthesis of compounds was achieved as follows: The various para substituted (H, CH3, F,Cl,Br, I) anilines were converted
to aryl ureas by reacting with sodium cyanate in the presence of glacial acetic acid. These aryl ureas and aryl semicarbazide s were
synthesized by allowing them to react with hydrazine hydrate. Finally the aryl semicarbazides were condensed with cyclohexanone/
cycloheptanone in the presence of sodium acetate to give title compounds. All the synthesized compounds were evaluated for
anticonvulsant activity by MES method using carbamazepine as standard and it was observed that all the compounds possess
anticonvulsant activity comparable to carbamazepine. Carbamazepine had shown the abolition in the hind limb extensor tonic
convulsion after 2 sec. whereas few compounds i.e. 1-cyclohexylidine-4-(4-fluorophenyl) semicarbazide, 1-cycloheptylidine-4-(4fluorophenyl) semi-carbazide and 1-cycloheptylidine-4-phenylsemicarbazide were more active than standard. Overall it was found
that cycloheptyl containing compounds were more active than cyclohexyl containing compounds. The unsubstitued compounds were
more active than halo derivatives i.e. electron withdrawing groups, and halo compounds were more active than methyl derivatives
i.e. electron donating group (CH3). The order of activity for cyclohexanone and cycloheptanone derivatives is as follows: H >F >Cl
>Br >I >CH3. Among the halo derivatives, the activity decreased with increasing molecular weight of halo substituents.
Keywords- cyclohexylidine; anticonvulsant; semicarbazide; cyproheptylidine.

I.

vigabatrin. These results triggered the search for newer
anticonvulsants [5].

INTRODUCTION

Epilepsy is a neurological disorder characterized by
unprovoked seizures that affect millions of people
worldwide. It is estimated that 25% of the epileptic
population have seizures that are not responsive to
presently available medical therapies. [1].

A number of aryl semicarbazones elicited antiMaximal Electroshock (MES) activity, as a result of
interaction of aryl ring and the semicarbazone group
(HNCONHN=) at aryl binding site and a hydrogen
bonding area respectively. Various p-substituted (Cl, Br)
phenylsemicarbazones were synthesized to confirm the
role of primary amino group in hydrogen bonding at the
receptor site.

Conventional
antiepileptic
drugs
(AEDs)
phenobarbital, primidone, phenytoin, carbamazepine,
ethosuximide and benzodiazepine, are widely used but
exhibit an unfavorable side effect profile and failure to
adequately control seizures [2]. It is estimated that
available medication controls the seizures in only 50%
of patients or decrease incidence in only 75% of
patients. These facts make the field of anticonvulsant
drug discovery a high priority [3]. The long-established
AEDs control seizures in 50% of patients developing
partial seizures and in 60-70% of those developing
generalized seizures [4]. Hence, there is an urgent need
to develop new AEDs.. Symptoms of depression were
significantly more likely to appear in patients taking

Semicarbazones as the lipophilic moiety resulted
in compounds with broad spectrum of anticonvulsant
activity and therefore, they may be utilized for the future
development of novel anticonvulsants with broad
spectrum of anticonvulsant activity [6, 7]. The
anticonvulsant activity of unsubstituted and mono-alkylsubstituted cyclohexanones was examined by testing the
ability of the compounds to inhibit seizures induced by
pentylenetrazol- and maximal electroshock in mice [8]. The
unsubstituted
cyclohexanone
prevented
both
pentylenetrazol- and maximal electroshock-induced
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seizures. On the other hand, cycloheptanone is used to
produce anticonvulsant compounds [9]. It is also used to
produce other anticonvulsant agents such as furan2(3H), 1'-cycloheptane]-3-one oxime maleate and furan2(3H), 1'-cycloheptane] hydrochloride. In the present
study we have converted semicarbazides to
semicarbazones by reacting with cyclic aldehydes or
ketones i.e. cyclohexanone and cycloheptanone.

in glacial acetic acid (10 mL) and diluted with water
(upto 100 mL). To this solution an equimolar (0.1 mol)
quantity of sodium cyanate in warm water (50 mL) was
added with stirring.

II. MATERIALS AND METHODS

B. Synthesis of arylsemicarbazides

Melting points were determined in open capiliry tubes
and are uncorrected on melting point apparatus. IR spectra
were recorded on Perkin Elmer Bx-1 IR spectrometer. 1H
NMR on Jeol-300D (300 MHz) using TMS as internal
standard.

The syntheses of arylsemicarbazides (IIIa-f) were
achieved as per scheme-1 [10].To an aqueous solution
of arylureas (II a-f; 0.1 mol); an equimolar quantity of
hydrazine hydrate was added. Ethanol (2 mL) was added
to this solution. The reaction mixture was refluxed for
30 min and cooled in ice. For p-substituted
phenylsemicarbazides (III a-f) NaOH (4 g) was added
to make the reaction mixture alkaline, before refluxing.
The product (III a-f) was filtered under suction and
recrystallized from ethanol.

The reaction mixture was allowed to stand for 30
min, and then compounds (II a-f) were filtered, washed
with water and dried after recrystallization from boiling
water.

C. Synthesis of Cyclohexylidine semicarbazide derivatives
Semicarbazides (III a-f; 0.1 mol) and sodium
acetate were dissolved in water in the molar ratio of
1:1.5 and then cyclohexanone (0.1 mol) was added to the
solution. The prepared solution was stirred well for an
hour at 35°C. The final solution appeared to be a turbid
mixture, then, ethanol was added to get a clear solution.
The volume of the reaction mixture was reduced to one
half by using rotary evaporator. The solution was left
overnight. The product so formed (IV a-f) was filtered
and recrystallized from ethanol. The characterization data
of compounds IVa-f is given in Table 1.
.

A. Synthesis of arylurease
The syntheses of arylurease (II a-f) were achieved
as per scheme-1 [10]. Aniline and/or p-substituted
aniline (CH3, F, Cl, Br, I; 0.1 mol; I a-f) was dissolved

TABLE 1: Characterization data of 1-Cyclohexylidine-4-substituted semicarbazides (IV a-f)

Comp.
No.

X

IUPAC name

%
yield

M.P.
(C)

IV-a

H

1-Cyclohexylidine-

64

65

IR (cm-1)

NMR δ (ppm)

180183

3423.4 NH Stretching Vibration (C-NHC), 3207.5 NH Stretching Vibration (CNH-N), 1654.2 C=O Stretching, 1585.6
C=N Stretching 917.9 -1009.7Cyclohexyl
Structural Vibration

-

195198

3423.3 NH Stretching Vibration (C-NHC), 3207.4 NH Stretching Vibration (CNH-N), 2905.3 CH Stretching of methyl
group, 1654.2 C=O Stretching, 1585.1
C=N Stretching, 917.8 -1009.6Cyclohexyl

-

4-phenylsemicarbazide

IV-b

CH3

1-Cyclohexylidine-4-ptolysemicarbazide
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structural Vibration

IV-c

F

1-Cyclohexylidine-4-

58

205209

(4-fluorophenyl)

3423.5 NH Stretching Vibration (C-NHC), 3207.6 NH Stretching Vibration (CNH-N), 1654.3 C=O Stretching, 1585.8

8.33 s, 1H, C-NH-N,
6.89 – 7.41m, 4H,
aromatic ring protons

semicarbazide

C=N Stretching, 1160.3 C-F Stretching,

6.09 s, 1H, C-NHC,1.09 – 1.48m, 10H,
Cyclohexyl ring
protons

917.1 – 1009.5 Cyclohexyl Structural
Vibration
IV-d

Cl

4-(4-chlorophenyl)

69

3423.1 NH Stretching Vibration (C-NH-C)

220224

1-Cyclohexylidine
semicarbazide

IV-e

Br

3207.3 NH Stretching Vibration (C-NHN), 1654.4 C=O Stretching,1585.3 C=N
Stretching, 917.5 – 1009.4 Cyclohexyl
Structural Vibration, 815.9 C-Cl
Stretching.

4-(4-bromophenyl)

62

229234

3423.6NH Stretching Vibration (C-NHC),3207.1NH Stretching Vibration (C-NHN), 1654.2C=O Stretching 1585.8 C=N
Stretching 917.9 -1009.1Cyclohexyl
Structural Vibration 547.3C-Br Stretching

-

63

240245

3423.6 NH Stretching Vibration (C-NHC), 3207.1 NH Stretching Vibration (CNH-N), 1654.6 C=O Stretching, 1585.2
C=N Stretching, 917.8 –
1009.3Cyclohexyl Structural Vibration,
510.3 C-I Stretching.

-

1-Cyclohexylidine
semicarbazide

IV-f

I

1-Cyclohexylidine-4-(4iodophenyl)
semicarbazide

8.38s, 1H, C-NHN,6.89 – 7.41,m, 4H,
aromatic ring protons,
6.12s, 1H, C-NH-C
1.09 – 1.48m,10H,
Cyclohexyl ring
protons

TABLE 2: Characterization data of 1- Cycloheptylidine-4-substituted semicarbazides (V a-f).

Comp.

No.

X

V-

V-b

H

CH3

IUPAC name

1-Cycloheptylidinea 4phenylsemicarbazide

1-Cycloheptylidine4-ptolysemicarbazide

%
yield

M.P.
(C)

64

185189

58

195198

IR

NMR

3423.5
NH
Stretching
Vibration (C-NHC), 3207.6 NH
Stretching
Vibration (C-NHN), 1654.3 C=O
Stretching,1585.6
C=N Stretching,
917.6 – 1009.7
Cycloheptyl
Structural
Vibration
3423.3
NH
Stretching
Vibration (C-NHC),
3207.5
NH
Stretching
Vibration (C-NHN), 2845.3 CH

-

-
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V-c

F

1-Cycloheptylidine4(4-fluorophenyl)
semicarbazide

56

205207

V-d

Cl

4-(4-chlorophenyl)
1-Cycloheptylidine
semicarbazide

51

215219

V-e

Br

4-(4-bromophenyl)
1-Cycloheptylidine
semicarbazide

59

225228

V-f

I

1-Cycloheptylidine4(4-iodophenyl)
semicarbazide

58

236240

Stretching
of
methyl
group,
1654.2
C=O
Stretching, 1585.6
C=N Stretching,
917.8–
1009.3Cycloheptyl
Structural
Vibration
3423.7
NH
Stretching
Vibration (C-NHC),
3207.9
NH
Stretching
Vibration (C-NHN),
1654.3C=O
Stretching,
1585.1C=N
Stretching
1162.3
C-F
Stretching,917.7 –
1009.4
Cycloheptyl
Structural
Vibration
3423.6
NH
Stretching
Vibration (C-NHC), 3207.8 NH
Stretching
Vibration (C-NHN), 1654.1 C=O
Stretching,
1585.2C=N
Stretching
917.9
–
1009.5Cycloheptyl
Structural
Vibration, 815.9 C
– Cl Stretching.
3423.7
NH
Stretching
Vibration (C-NHC),
3207.4
NH
Stretching
Vibration (C-NHN), 1654.2 C=O
Stretching,
1585.5
C=N
Stretching,
917.9 – 1009.6
Cycloheptyl
Structural
Vibration, 547.3
C-Br Stretching.
3423.9
NH
Stretching
Vibration (C-NHC),
3207.5
NH

8.35 s, 1H, C-NH-N,
6.89 – 7.41m, 4H,
aromatic ring protons,
6.18 s, 1H, C-NHC,1.09 – 1.48 m, 12H,
Cycloheptyl
ring
protons

8.37s, 1H, C-NH-N,
6.89 – 7.41m, 4H,
aromatic ring protons,
6.14,s, 1H, C-NHC,1.09 – 1.48
m, 12H, Cycloheptyl
ring protons

-

-
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Stretching
Vibration (C-NHN), 1654.4 C=O
Stretching,
1585..6C=N
Stretching, 917.9 –
1009.3
Cycloheptyl
Structural
Vibration, 510.3CI Stretching.

.
D.

Synthesis of Cycloheptylidine semicarbazide derivative

controlled and standard drug (carbamazepine) treated
groups. The data is given in Table 3.

Semicarbazides (III a-f; 0.1 mol) and sodium
acetate were dissolved in water in the molar ratio of
1:1.5 and then cycloheptanone (0.1 mol) was added to
the solution. The prepared solution was stirred well for
an hour at 35°C. The final solution appeared to be a
turbid mixture, then, ethanol was added to get a clear
solution. The volume of the reaction mixture was
reduced to one half by using rotary evaporator. The
solution was left overnight. The product so formed (V af) was filtered and recrystallized from ethanol. The
characterization data of compounds V a-f is given in
Table 2.
E. Pharmacological
compounds

Screening

of

III. RESULTS, DISCUSSION AND CONCLUSION
All the title compounds were synthesized
successfully and were characterized by IR and NMR.
The characterization data of compounds IVa-f and V a-f
is given in Table 1 and 2 respectively.
Anticonvulsant activity was performed by using
abolition time of hind limb extensor in albino rats. The
result of anticonvulsant activity is shown in Table 3.
All synthesized compounds showed anticonvulsant
activity comparable to that of standard drug
(carbamazepine). Carbamazepine had shown abolition
in hind limb extension after 2 seconds. Few compounds
showed activity equal to carbamazepine and even better
than that of carbamazepine. Other compounds showed
moderate activity, little lesser but comparable to that of
carbamazepine. The most active compound V-c had
shown abolition in hind limb extension after 1 second,
which had F at aromatic ring and cycloheptyl moiety.
The least active compound IV-b had shown abolition in
hind limb extension after 4 seconds, which had CH3 at
aromatic ring and cyclohexyl moiety.

synthesized

All the synthesized semicarbazide compounds have
been screened for their possible anticonvulsant activity
on albino rats using the apparatus Techno
Electrocunvulsiometer with eye (corneal) electrodes,
etc.
Suspension of all synthesized compounds were
made (0.008 mol), according to their molecular weight,
by using sodium carboxymethylcellulose (as suspending
agent) in water and 0.3 mL of this suspension was
injected intraperitoneally in albino rats.

F. Cyclohexylidine semicarbazide derivatives

Groups of 3 albino rats were used. The test was
started 30 min. after i.p. injection with the test
compounds or the vehicle or standard drug
(carbamazepine).
Techno
Electrocunvulsiometer
apparatus with corneal electrodes was used to deliver
the stimuli. The intensity of stimulus is dependent on the
apparatus 15mA, 75Hz for 0.2 sec. Under these
conditions all vehicles/ standard drug (carbamazepine)/
compounds treaded mice showed the characteristic
extensor tonus. The animals were observed closely for 2
min. Disappearance of hind limb extensor tonic
convulsion was used as positive criterion.

The unsubstituted compound is more active than
electron-donating group (CH3) substituted compound
but is less active than electron withdrawing group (F, Cl,
Br, I) substituted compounds. In halo substituted
compounds, the fluoro derivative is most active than
chloro, bromo and iodo derivatives. The anticonvulsant
activity is in the following order for the halo derivatives
of cyclohexanone i.e. F > Cl > Br > I (IV c > IV d > IV
e > IV f). The activity decreased with increasing
molecular weight of halo substituents.
G. Cycloheptylidine semicarbazide derivatives
The unsubstituted compound is more active than
electron donating group (CH3) substituted compound

The abolition of hind limb extensor of synthesized
compounds treated groups were compared with that of
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but is less active than electron withdrawing group (F, Cl,
Br, I) substituted compounds. In halo substituted
compounds, the fluoro derivative is most active than
chloro, bromo and iodo derivatives. The anticonvulsant
activity is in the following order for the halo derivatives
of cycloheptanone i.e. F > Cl > Br > I (V c > V d > V e
> V f). The activity decreased with increasing molecular
weight of halo substituents.
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In general, it was found that the cycloheptyl moiety
containing compounds are more active than cyclohexyl
moiety containing compounds.
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